Answers are grounded in this paper and cite their sources.
We recently described two novel aryl binding sites of farnesyltransferase. The 4- and 5-arylsubstituted thienylacryloyl moieties turned out as appropriate substituents for our benzophenone-based AAX-peptidomimetic capable for occupying the far aryl binding site.
No takes yet. Share an insight, caveat, or question.
Mitsch et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: